Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Toussirot

Showing results (11-20 of 146) with videos related to

Pageof 15
Sort By:
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current InsightsEric Toussirot
Frontiers in Endocrinology|January 11, 2021
Mini-Review: The Contribution of Adipokines to Joint Inflammation in Inflammatory Rheumatic DiseasesEric Toussirot
Biomedicines|February 25, 2023
The Influence of Adipokines on Radiographic Damage in Inflammatory Rheumatic DiseasesEric Toussirot
Expert Opinion on Pharmacotherapy|May 17, 2019
Pharmacological management of axial spondyloarthritis in adultsEric Toussirot
Best Practice & Research. Clinical Rheumatology|November 26, 2008
Epstein-Barr virus in autoimmune diseasesEric Toussirot, Jean Roudier
Expert Opinion on Pharmacotherapy|March 12, 2004
The use of TNF-alpha blocking agents in rheumatoid arthritis: an overviewEric Toussirot, Daniel Wendling
The Journal of Rheumatology|December 7, 2005
Bacillus calmette-guérin vaccination in a patient treated with infliximabEric Toussirot, Daniel Wendling
Drugs & Aging|October 30, 2023
Current Pharmacological Therapies for the Management of Spondyloarthritis: Special Considerations in Older PatientsRenaud Felten, Eric Toussirot
Arthritis Research & Therapy|August 29, 2014
Response to 'Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort'- authors' replyEric Toussirot, Gilles Dumoulin
Expert Opinion on Pharmacotherapy|January 9, 2003
Recent progress in ankylosing spondylitis treatmentEric Toussirot, Daniel Wendling
Pageof 15

Showing results (11-20 of 146) with videos related to

Sort By:
Pageof 15
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current InsightsEric Toussirot
Frontiers in Endocrinology|January 11, 2021
Mini-Review: The Contribution of Adipokines to Joint Inflammation in Inflammatory Rheumatic DiseasesEric Toussirot
Biomedicines|February 25, 2023
The Influence of Adipokines on Radiographic Damage in Inflammatory Rheumatic DiseasesEric Toussirot
Expert Opinion on Pharmacotherapy|May 17, 2019
Pharmacological management of axial spondyloarthritis in adultsEric Toussirot
Best Practice & Research. Clinical Rheumatology|November 26, 2008
Epstein-Barr virus in autoimmune diseasesEric Toussirot, Jean Roudier
Expert Opinion on Pharmacotherapy|March 12, 2004
The use of TNF-alpha blocking agents in rheumatoid arthritis: an overviewEric Toussirot, Daniel Wendling
The Journal of Rheumatology|December 7, 2005
Bacillus calmette-guérin vaccination in a patient treated with infliximabEric Toussirot, Daniel Wendling
Drugs & Aging|October 30, 2023
Current Pharmacological Therapies for the Management of Spondyloarthritis: Special Considerations in Older PatientsRenaud Felten, Eric Toussirot
Arthritis Research & Therapy|August 29, 2014
Response to 'Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort'- authors' replyEric Toussirot, Gilles Dumoulin
Expert Opinion on Pharmacotherapy|January 9, 2003
Recent progress in ankylosing spondylitis treatmentEric Toussirot, Daniel Wendling
Pageof 15